RNA interference targeting Slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA

International Journal of Molecular Sciences

Volumn 12, Issue 1, 2011, Pages 385-400

  Zhang, Kejun ^a   Chen, Dong ^a   Wang, Xingang ^a   Zhang, Shaoyan ^a   Wang, Jigang ^a   Gao, Yuan ^a   Yan, Bomin ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Chemotherapy; Cisplatin; E cadherin; PUMA; Slug

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; LIPOCORTIN 5; PLASMID DNA; PUMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BBC3 PROTEIN, HUMAN; ONCOPROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CYCLE; DRUG EFFECTS; GENETICS; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CISPLATIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 79251610744     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12010385     Document Type: Article

References (44)

1. De Groen, P.C.; Gores, G.J.; LaRusso, N.F.; Gunderson, L.L.; Nagorney, D.M. Biliary tract cancers. N. Engl. J. Med. 1999, 341, 1368-1378.
2. Malouf, G.; Dreyer, C.; Guedj, N.; Paradis, V.; Degos, F.; Belghiti, J.; Le Tourneau, C.; Faivre, S.; Raymond, E. Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools. Bull. Cancer 2009, 96, 405-415.
3. Lang, M.; Henson, R.; Braconi, C.; Patel, T. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int. 2009, 29, 670-677.
4. Leelawat, K.; Narong, S.; Udomchaiprasertkul, W.; Leelawat, S.; Tungpradubkul, S. Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. Cancer Cell Int. 2009, 8, 3.
5. Wehbe, H.; Henson, R.; Lang, M.; Meng, F.; Patel, T. Pifithrin-alpha enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes. J. Pharmacol. Exp. Ther. 2006, 319, 1153-1161.
6. Carl, T.F.; Dufton, C.; Hanken, J.; Klymkowsky, M.W. Inhibition of neural crest migration in Xenopus using antisense Slug RNA, Dev. Biol. 1999, 213, 101-115.
7. Hemavathy, K.; Guru, S.C.; Harris, J.; Chen, J.D.; Ip, Y.T. Human Slug is a repressor that localizes to sites of active transcription. Mol. Cell. Biol. 2000, 20, 5087-5095.
8. Nieto, M.A.; Sargent, M.G.; Wilkinson, D.G.; Cooke, J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994, 264, 835-839.
9. Savagner, P.; Karavanova, I.; Perantoni, A.; Thiery, J.P.; Yamada, K.M. Slug mRNA is expressed by specific mesodermal derivatives during rodent organogenesis. Dev. Dyn. 1998, 213, 182-187.
10. Sefton, M.; Sanchez, S.; Nieto, M.A. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 1998, 125, 3111-3121.
11. Côme, C.; Magnino, F.; Bibeau, F.; De Santa Barbara, P.; Becker, K.F.; Theillet, C.; Savagner, P. nail and slug play distinct roles during breast carcinoma progression. Clin. Cancer Res. 2006, 12, 5395-5402.
12. Uchikado, Y.; Natsugoe, S.; Okumura, H.; Setoyama, T.; Matsumoto, M.; Ishigami, S.; Aikou, T. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2005, 11, 1174-1180.
13. Shioiri, M.; Shida, T.; Koda, K.; Oda, K.; Seike, K.; Nishimura, M.; Takano, S.; Miyazaki, M. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer 2006, 94, 1816-1822.
14. Alves, C.; Rosivatz, E.; Schott, C. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J. Pathol. 2007, 211, 507-515
15. Jethwa, P.; Naqvi, M.; Hardy, R.G.; Hotchin, N.A.; Roberts, S.; Spychal, R.; Tselepis, C. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J. Gastroenterol. 2008, 14, 1044-1052.
16. Zhang, K.J.; Wang, D.S.; Zhang, S.Y.; Jiao, X.L.; Li, C.W.; Wang, X.S.; Yu, Q.C.; Cui, H.N. The E-cadherin repressor slug and progression of human extrahepatic hilar Cholangiocarcinoma. J. Exp. Clin. Cancer Res. 2010, 29, 88.
17. Haupt, S.; Alsheich-Bartok, O.; Haupt, Y. Clues from worms: a Slug at Puma promotes the survival of blood progenitors. Cell. Death Differ. 2006, 13, 913-915.
18. Wu, W.S.; Heinrichs, S.; Xu, D.; Garrison, S.P.; Zambetti, G.P.; Adams, J.M.; Look, A.T. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123, 641-653.
19. Yu, J.; Yue, W.; Wu, B.; Zhang, L. PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin. Cancer Res. 2006, 12, 2928-2936.
20. Catalano, A.; Rodilossi, S.; Rippo, M.R.; Caprari, P.; Procopio, A. Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells. J. Biol. Chem. 2004, 279, 46706-46714.
21. Vitali, R.; Mancini, C.; Cesi, V.; Tanno, B.; Mancuso, M.; Bossi, G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin. Cancer Res. 2008, 14, 4622-4630.
22. Vitali, R.; Mancini, C.; Cesi, V. Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models. Clin. Cancer Res. 2008, 14, 4622.
23. Vannini, I.; Bonafeb, M.; Tesei, A. Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and otemustine. Cell. Oncol. 2007, 29, 279-287.
24. Spencer, H.L.; Eastham, A.M.; Merry, C.L. E-Cadherin inhibits cell surface localization of the pro- migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol. Biol. Cell 2007, 18, 2838-2851.
25. Yu, J.; Zhang, L. PUMA, a potent killer with or without p53. Oncogene 2008, 27, S71-S83.
26. Tonini, G.; Virzì, V.; Fratto, M.E.; Vincenzi, B.; Santini, D. Targeted therapy in biliary tract cancer: 2009 update. Future Oncol. 2009, 5, 1675-1684.
27. Wongkham, S.; Junking, M.; Wongkham, C.; Sripa, B.; Chur-In, S.; Araki, N. Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Sci. 2009, 100, 2077-2084.
28. Delbaldo, C.; Laurent, A.; Grenier, J.; Cherqui, D.; Luciani, A.; Piedbois, P. Management of biliary tract carcinomas. Rev. Prat. 2009, 59, 469-473.
29. Morise, Z.; Sugioka, A.; Tanahashi, Y.; Okabe, Y.; Ikeda, M.; Kagawa, T.; Takeura, C. Treatment of patients with unresectable advanced carcinoma of biliary tract-chemotherapy and surgical resection. Anticancer Res. 2009, 29, 1783-1786.
30. Shimizu, M.; Suzui, M.; Deguchi, A.; Lim, J.T.; Xiao, D.; Hayes, J.H.; Papadopoulos, K.P.; einstein, I.B. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells. Clin. Cancer Res. 2004, 10, 6710-6721.
31. Cheong, J.W.; Chong, S.Y.; Kim, J.Y.; Eom, J.I.; Jeung, H.K.; Maeng, H.Y.; Lee, S.T.; Min, Y.H. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Clin. Cancer Res. 2003, 9, 5018-5027.
32. Aikou, T. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2005, 11, 1174-1180.
33. Martin, T.A.; Goyal, A.; Watkins, G.; Jiang, W.G. Expression of the transcription factors snail, lug, and twist and their clinical significance in human breast cancer. Ann. Surg. Oncol. 2005, 12, 488-496.
34. Shioiri, M.; Shida, T.; Koda, K. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer 2006, 94, 1816-1822.
35. Zhang, K.J.; Zhang, B.Y.; Zhang, K.P.; Tang, L.M.; Liu, S.S.; Zhu, D.M. Zhang, D.L. Clinicopathologic significance of slug expression in human intrahepatic Cholangiocarcinoma. World J. Gastroenterol. 2010, 16, 2554-2557.
36. Maier, P.; Herskind, C.; Zeller, W.J.; Wenz, F. SLUG as a novel radioprotector of normal tissue by gene transfer using a lentiviral bicistronic SIN vector. Rad. Oncol. 2009, 7, S27-S28.
37. Mancini, M.; Petta, S.; Iacobucci, I.; Salvestrini, V.; Barbieri, E.; Santucci, M.A. Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Cell Signal 2010, 22, 1247-1253.
38. Cha, H.S.; Bae, E.K.; Ahn, J.K.; Lee, J.; Ahn, K.-S.; Koh, E.-M. Slug suppression induces apoptosis via Puma transactivation in rheumatoid arthritis fibroblast-like synoviocytes treated with hydrogen peroxide. Exp. Mol. Med. 2010, 6, 428-436.
39. Vitali, R.; Mancini, C.; Cesi, V.; Tanno, B.; Mancuso, M.; Bossi, G.; Zhang, Y.; Martinez, R.V.; Calabretta, B.; Dominici, C.; Raschellà, G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin. Cancer Res. 2008, 14, 4622-4630.
40. Vannini, I.; Bonafeb, M.; Tesei, A.; Rosetti, M.; Fabbri, F.; Storci, G.; Ulivi, P.; Brigliadori, G.; Amadori, D.; Zoli, W. Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine. Cell. Oncol. 2007, 29, 279-287.
41. Konstantakou, E.G.; Voutsinas, G.E.; Karkoulis, P.K.; Aravantinos, G.; Margaritis, L.H. Stravopodis D.J. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses. Int. J. Oncol. 2009, 35, 401-416.
42. Tsuruya, K.; Yotsueda, H.; Ikeda, H.; Taniguchi, M.; Masutani, K.; Hayashida, H.; Hirakata, H.; Iida, M. Involvement of p53-transactivated Puma in cisplatin-induced renal tubular cell death. Life Sci. 83, 550-556.
43. St. Germain, C.; Niknejad, N.; Ma, L.; Garbuio, K.; Hai, T.; Dimitroulakos, J. Cisplatin induces ytotoxicity through the mitogen-activated protein kinase pathways and activating transcription. eoplasia 2010, 12, 527-538.
44. Sun, Q.; Sakaida, T.; Yue, W.; Gollin, S.M.; Yu, J. Chemosensitization of head and neck cancer cells by PUMA. Mol. Cancer Ther. 2007, 6, 3180-3188.